On February 10, 2025, Bio-Thera Solutions, Ltd. announced that they entered into an exclusive licensing agreement with Intas Pharmaceuticals Ltd. to commercialize BAT2506 (golimumab), Bio-Thera’s ...
Please provide your email address to receive an email when new articles are posted on . Alvotech’s AVT05 showed therapeutic equivalence with golimumab in DAS28-CRP score change at 16 weeks. The ...
Drinking diet soda or sugary drinks daily may increase the risk of metabolic dysfunction-associated steatotic liver disease (MASLD), a study presented at the United European Gastroenterology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback